Aspiration to architecture: multi-omics, AI, digital twins, and blockchain for P4 medicine.
Integrating multi-omics with AI and digital twins could transform personalized medicine, though this ambitious framework requires independent clinical validation.
This perspective from commercial precision medicine developers proposes a four-pillar framework linking multi-omics, AI, digital twins, and blockchain to make P4 medicine operational, including preliminary metabolomics data identifying age-associated metabolites from 2,072 individuals. While conceptually ambitious, the framework combines commercial interests (Theriome Inc.) with preliminary data that requires independent validation.
What the study was
- Study design
- Perspective/conceptual framework with preliminary metabolomics data (n=2,072)
- Population
- 2,072 individuals with de-identified dried blood spot samples (Theriome Inc. commercial platform)
- Sample size
- 2072
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Journal of translational medicine
Why it surfaced
Conceptual framework with limited preliminary data; commercial interest COI; J Transl Med perspective. Useful for pipeline context on digital health integration direction.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.